ALPS ETF Trust has released its latest NPORT-P report, detailing its financial position as of August 31, 2026. The filing, submitted on October 29, 2026, reveals total assets of approximately $56.45 million and net assets of about $56.42 million. This update is significant as it underscores the company's ongoing commitment to transparency and accountability in the investment sector.
The report indicates that ALPS ETF Trust is maintaining a stable financial foundation, with total liabilities reported at $33,222.94. This financial health is essential for investors looking for reliable investment options in the real estate investment trust (REIT) industry.
Background
ALPS ETF Trust is an investment company based in Denver, Colorado, with a focus on providing exchange-traded funds (ETFs) that cater to various investment strategies. The company operates under the SEC file number 811-22175. The trust's fiscal year ends on November 30, and it has been actively filing reports to keep its investors informed about its financial status.
What the Filing Says
The recent NPORT-P filing provides a snapshot of ALPS ETF Trust's financials. It states, "Total assets: $56,452,997.81; Total liabilities: $33,222.94; Net assets: $56,419,774.87." This data reflects the company's strong asset base and minimal liabilities, indicating a solid financial position.
Impact
This filing may affect various stakeholders, including investors, analysts, and competitors within the REIT sector. The transparency shown in the report can enhance investor confidence, potentially attracting more capital into the fund. Additionally, competitors in the REIT market might need to assess their own financial positions in light of ALPS ETF Trust's stable performance.
What's Next
The filing does not specify what happens next for ALPS ETF Trust. However, investors will likely be monitoring future filings to gauge the company's ongoing performance and investment strategies.
Read Next
Jefferies CEO Handler Reports Stock Transactions in SEC Filing
Brophy Michael Burkes sells 3,084 shares of Natera stock
Glenbrook Capital Management Boosts Stake in SenesTech
OS Therapies grants stock options to Chief Medical Officer
Belite Bio CEO Lin Yu-Hsin Vests 5,000 Shares
Chen Wan-Shan Reports Share Transaction for Belite Bio






